ArticleFrontiers in oncology2025
Response and prognosis to neoadjuvant chemotherapy in women early breast cancer of HER2-low status.
Yongtao Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it